Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Medicine Corp. Closes JPMorgan Funding

publication date: Feb 2, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Medicine announced it has closed a previously announced private placement that raised $69.6 million from One Equity Partners, the private equity investment arm of JP Morgan Chase & Co. The size and structure of the deal have not changed since it was originally announced, one month ago, though China Medicine did add that the net proceeds of the funding will be $66.5 million. More details...

Stock Symbol: (OCTBB: CHME)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...